- Home
- RBOT vs ALGS Comparison
RBOT vs ALGS Comparison
Compare RBOT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- ALGS
- Stock Information
- Founded
- RBOT 2014
- ALGS 2018
- Country
- RBOT United States
- ALGS United States
- Employees
- RBOT N/A
- ALGS N/A
- Industry
- RBOT Medical Specialities
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- RBOT Health Care
- ALGS Health Care
- Exchange
- RBOT Nasdaq
- ALGS Nasdaq
- Market Cap
- RBOT 45.8M
- ALGS 53.0M
- IPO Year
- RBOT N/A
- ALGS 2020
- Fundamental
- Price
- RBOT $9.32
- ALGS $7.69
- Analyst Decision
- RBOT Hold
- ALGS Strong Buy
- Analyst Count
- RBOT 1
- ALGS 1
- Target Price
- RBOT $8.50
- ALGS $70.00
- AVG Volume (30 Days)
- RBOT 35.2K
- ALGS 68.3K
- Earning Date
- RBOT 08-12-2025
- ALGS 08-06-2025
- Dividend Yield
- RBOT N/A
- ALGS N/A
- EPS Growth
- RBOT N/A
- ALGS N/A
- EPS
- RBOT N/A
- ALGS N/A
- Revenue
- RBOT N/A
- ALGS $3,174,000.00
- Revenue This Year
- RBOT N/A
- ALGS N/A
- Revenue Next Year
- RBOT N/A
- ALGS $51.55
- P/E Ratio
- RBOT N/A
- ALGS N/A
- Revenue Growth
- RBOT N/A
- ALGS N/A
- 52 Week Low
- RBOT $4.27
- ALGS $3.76
- 52 Week High
- RBOT $19.00
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- RBOT 50.57
- ALGS 45.44
- Support Level
- RBOT $8.69
- ALGS $7.09
- Resistance Level
- RBOT $9.58
- ALGS $8.42
- Average True Range (ATR)
- RBOT 0.94
- ALGS 0.79
- MACD
- RBOT -0.21
- ALGS -0.13
- Stochastic Oscillator
- RBOT 15.63
- ALGS 27.98
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.